Woodline Partners’s Arbutus Biopharma ABUS Stock Holding History

Woodline Partners’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.05M	Sell	2,010,172 -176,381	-8%	-$771K	0.03%	537
2025 Q4	$10.5M	Buy	2,186,553 +20,951	+1%	+$94.2K	0.04%	450
2025 Q3	$9.83M	Sell	2,165,602 -332,382	-13%	-$1.22M	0.05%	445
2025 Q2	$7.72M	Sell	2,497,984 -157,754	-6%	-$524K	0.04%	478
2025 Q1	$9.27M	Buy	2,655,738 +1,684,110	+173%	+$5.62M	0.06%	373
2024 Q4	$3.18M	Buy	971,628 +303,475	+45%	+$1.12M	0.02%	577
2024 Q3	$2.57M	Sell	668,153 -258,381	-28%	-$991K	0.02%	449
2024 Q2	$2.86M	Sell	926,534 -3,144,125	-77%	-$9.43M	0.03%	389
2024 Q1	$10.5M	Sell	4,070,659 -649,244	-14%	-$1.68M	0.1%	258
2023 Q4	$11.8M	Hold	4,719,903	–	–	0.13%	210
2023 Q3	$9.58M	Buy	4,719,903 +2,250,706	+91%	+$4.72M	0.11%	229
2023 Q2	$5.68M	Sell	2,469,197 -188,408	-7%	-$490K	0.07%	273
2023 Q1	$8.05M	Buy	+2,657,605	New	+$7.5M	0.11%	228
2021 Q4	–	Sell	-496,172	Closed	-$2.13M	–	697
2021 Q3	$2.13M	Buy	+496,172	New	+$1.65M	0.04%	407
2021 Q2	–	Sell	-78,339	Closed	-$261K	–	587
2021 Q1	$261K	Buy	+78,339	New	+$302K	0.01%	405

Other funds holding ABUS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return

Whitefort Capital Management New York $329M AUM 52.48% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return